Latest filing published 06 Dec 2022 for Sanara MedTech Inc., €36k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Shawn M. Bowman: trading record in brief
Shawn M. Bowman is a declared insider of Sanara MedTech Inc. (chief executive), with filings sourced from SEC (Form 4). Between 21 January 2020 and 2 December 2022, the trades on record add up to 29 filings.
Every open-market trade on record is a sale: 6 sales worth €105k. Outside the open market, there are 19 share grants. So far in 2022, the count stands at no purchases and 3 sales.
Most recently, on 6 December 2022, the filings show a share grant worth €39k in Sanara MedTech Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shawn M. Bowman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,224 shares@ US$30.7922.7% of flowCommon StockSEC:0001493152-22-034632:0
- 660 shares@ US$27.5411.7% of flowCommon StockSEC:0001493152-22-026823:0
- 1,000 shares@ US$20.020.0071% mcap18.4% of flowCommon StockSEC:0001493152-22-017378:0
- 2,284 shares0Common StockSEC:0001493152-22-006528:0
- 3,195 shares0Common StockSEC:0001493152-21-032526:0
- 123 shares@ US$45.674.3% of flowCommon StockSEC:0001493152-21-032037:0
- 300 shares@ US$33.477.5% of flowCommon StockSEC:0001654954-21-011258:0
- 13,555 shares0Common StockSEC:0001654954-21-010614:0
- 1,000 shares@ US$33.3324.7% of flowCommon StockSEC:0001654954-21-010616:0
9 of 9 declarations
